New suction device aims to reduce stress in preterm infants
NCT ID NCT06443970
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new FDA-approved suction device (EXSALTA) to standard suctioning in 30 preterm and term infants who are on breathing tubes. The goal is to see if the new device causes smaller changes in heart rate, oxygen levels, and brain oxygen levels during suctioning. Each baby will receive both methods in a random order, and researchers will monitor for episodes of slow heart rate or low oxygen.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Exsalta Suction Device
What this could lead to
If successful, this could lead to a gentler suctioning method for babies on breathing tubes, reducing stress on their heart and oxygen levels.
What could go wrong
This is a small, early-stage study with only 30 infants, so results may not apply to all babies. The new device may not show meaningful benefits over standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center
RECRUITINGNew York, New York, 10032-3720, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••